← Back to Search

2-Octyl Cyanoacrylate for Scar

N/A
Waitlist Available
Led By Daniel Eisen, MD
Research Sponsored by University of California, Davis
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Patient scheduled for cutaneous surgical procedure on the face or neck with predicted primary closure.
Willing to return for follow up visit
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 3 months
Awards & highlights

Study Summary

This trial is investigating whether using surgical glue on top of wounds following skin surgery on the head or neck results in better cosmetic outcomes and if patients prefer this method of wound care.

Eligible Conditions
  • Scarring

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
You are going to have a skin surgery on your face or neck that will require stitches to close.
Select...
You agree to come back for follow-up appointments.
Select...
You can understand the study information and agree to participate on your own.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~3 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Scar Assessment as measured by Patient Observer Scar Assessment Score (POSAS)
Width of Scar as measured using Trace-to-Tape Method
Secondary outcome measures
Complications or Adverse Events from Treatment

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Layered Closure with 2-Octyl CyanoacrylateExperimental Treatment1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).
Group II: Layered ClosureActive Control1 Intervention
One half of the wound will have a cutaneous layer of sutures (2 layers), as is standard of care, while the other half of the wound will have an additional layer of 2-octyl cyanoacrylate (3 layers).

Find a Location

Who is running the clinical trial?

University of California, DavisLead Sponsor
910 Previous Clinical Trials
4,706,941 Total Patients Enrolled
8 Trials studying Scarring
383 Patients Enrolled for Scarring
Daniel Eisen, MDPrincipal InvestigatorUniversity of California, Davis
8 Previous Clinical Trials
431 Total Patients Enrolled
4 Trials studying Scarring
200 Patients Enrolled for Scarring

Media Library

2-Octyl cyanoacrylate Clinical Trial Eligibility Overview. Trial Name: NCT05449457 — N/A
Scarring Research Study Groups: Layered Closure, Layered Closure with 2-Octyl Cyanoacrylate
Scarring Clinical Trial 2023: 2-Octyl cyanoacrylate Highlights & Side Effects. Trial Name: NCT05449457 — N/A
2-Octyl cyanoacrylate 2023 Treatment Timeline for Medical Study. Trial Name: NCT05449457 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any participants being accepted for this experiment?

"Presently, the clinical trial is actively enrolling participants. This study was first made available on October 6th 2022 and underwent an update last November 1st."

Answered by AI

How many people are currently enrolled in this clinical study?

"Affirmative, medical data on clinicaltrials.gov affirms that this trial is currently enrolling participants. The study was initially posted October 6th 2022 and the most recent update occurred November 1st 2022. This research requires 50 patients to be enrolled from a single clinic."

Answered by AI

Who else is applying?

What state do they live in?
Washington
What site did they apply to?
University of California, Davis - Dermatology Department
What portion of applicants met pre-screening criteria?
Met criteria
How many prior treatments have patients received?
1
~20 spots leftby Apr 2025